Yunfeng Lu received his PhD in Chemical Engineering from the University of New Mexico. After his postdoc training at the Sandia National Laboratories, he joined Applied Materials as a senior processing engineer and Tulane University as an assistant professor. Currently, he is a professor of Chemical and Biomolecular Engineering, the University of California Los Angeles (UCLA). His research has been focused on material design and synthesis towards nanomedicine and energy applications (e.g., lithium-ion batteries, supercapacitors and fuel cells). In the nanomedicine area, he has developed a platform technology that enables delivery of protein therapeutics for treatments of acute alcohol intoxication, gout, and central-nerve-system diseases (e.g., brain cancers, stroke, and spinal cord injury), COVID-19, and other diseases. He has published more than 280 papers with 28,400 citations and a H-index of 76, and received many prestigious awards including a Presidential Early Career Award for Scientists and Engineers (PECASE).